Trial Profile
Open-Label, Multi-Center, Non-Interventional Study in Rheumatoid Arthritis (RA) Patients Treated With Tocilizumab SC Monotherapy in Daily Clinical Practice
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 08 Nov 2019
Price :
$35
*
At a glance
- Drugs Tocilizumab (Primary)
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- Acronyms SIMPACT
- Sponsors Roche
- 21 Feb 2019 Status changed from active, no longer recruiting to completed.
- 30 Jul 2018 Status changed from recruiting to active, no longer recruiting.
- 23 Aug 2017 Planned number of patients changed from 200 to 350.